No Data
No Data
What Makes Elevation Oncology (ELEV) a New Strong Buy Stock
Empery Asset Management's Strategic Acquisition in Elevation Oncology
Express News | Biden-Harris Administration Proposes Medicare $2 Drug List Model To Lower Prescription Costs; CMS Seeks Feedback On Sample Drug List And Outreach With Voluntary Participation For Part D Sponsors Starting As Early As Jan 2027; Model To Include Drugs...
12 Health Care Stocks Moving In Friday's After-Market Session
Elevation Oncology's EO-3021 Granted FDA Fast Track for Advanced Gastric Cancer Treatment
Express News | Elevation Oncology: Look to Advancing Through Monotherapy Dose Expansion, Reporting More Data From Ongoing Trial in H1 2025
No Data
No Data